Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth [Yahoo! Finance]
Thermo Fisher Scientific Inc (TMO)
Last thermo fisher scientific inc earnings: 4/22 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
ir.thermofisher.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
Dublin, March 30, 2026 (GLOBE NEWSWIRE) -- The "Carcinoid Tumor Market Report 2026" has been added to ResearchAndMarkets.com's offering. The global carcinoid tumor market is rapidly expanding, with projections showing it will surge from $1.77 billion in 2025 to $1.96 billion in 2026, achieving a CAGR of 10.5%. By 2030, the market is expected to reach $2.88 billion, driven by an increased focus on rare cancer treatments, advanced oncology care facilities, and novel therapies. Enhanced neuroendocrine tumor research and growing availability of somatostatin analog treatments are critical factors contributing to this growth. Over the forecast period, innovation in targeted therapies, precision oncology, and personalized treatment plans will significantly boost the carcinoid tumor market. Key trends include the rising adoption of combination drug regimens, early tumor diagnosis emphasis, and specialized oncology treatment center expansion. The obesity epidemic is a major growth drive
Show less
Read more
Impact Snapshot
Event Time:
TMO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMO alerts
High impacting Thermo Fisher Scientific Inc news events
Weekly update
A roundup of the hottest topics
TMO
News
- Signant Health Appoints Specialist Physician and Clinical Research Expert Dr. Graham C. Ellis as Clinical Vice President to Strengthen Metabolic Disease and Diabetes Trial Capabilities [Yahoo! Finance]Yahoo! Finance
- Thermo Fisher Scientific Introduces the Gibco™ CTS™ Compleo™ Fill and Finish System to Help Streamline Cell Therapy Manufacturing [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Environmental Mass Spectrometry Market Size/Share Worth USD 6.47 Billion by 2035 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [Yahoo! FinanceLatest
- ?????????????:2026???2036???????? [CNET News]CNET News
- Thermo Fisher Scientific Launches Integrated Platform to Accelerate Biologics Development [Yahoo! Finance]Yahoo! Finance
TMO
Earnings
- 1/29/26 - Beat
TMO
Sec Filings
- 4/7/26 - Form ARS
- 4/7/26 - Form DEFA14A
- 4/7/26 - Form DEF
- TMO's page on the SEC website